[HTML][HTML] Neoplastic bone marrow niche: hematopoietic and mesenchymal stem cells
The neoplastic niche comprises complex interactions between multiple cell types and
molecules requiring cell-cell signaling as well as local secretion. These niches are important …
molecules requiring cell-cell signaling as well as local secretion. These niches are important …
[HTML][HTML] Association of chromosomal translocation and miRNA expression with the pathogenesis of multiple myeloma
Multiple myeloma (MM), is the second most common blood cancer after non-Hodgkin's
lymphoma. Genetic changes, structural and numerical chromosome anomalies, are involved …
lymphoma. Genetic changes, structural and numerical chromosome anomalies, are involved …
[PDF][PDF] Effects of EDTA on routine and specialized coagulation testing and an easy method to distinguish EDTA-treated from citrated plasma samples
RA Crist, K Gibbs, GM Rodgers… - Laboratory …, 2009 - researchgate.net
Coagulation testing is performed with citrate-treated plasma. Samples submitted in other
anticoagulants, such as EDTA, should not be tested. We aimed to evaluate the effects of …
anticoagulants, such as EDTA, should not be tested. We aimed to evaluate the effects of …
[HTML][HTML] Effect of The Receptor Activator of Nuclear Factor кB and RANK Ligand on In Vitro Differentiation of Cord Blood CD133+ Hematopoietic Stem Cells to …
Objective Receptor activator of nuclear factor-kappa B ligand (RANKL) appears to be an
osteoclast-activating factor, bearing an important role in the pathogenesis of multiple …
osteoclast-activating factor, bearing an important role in the pathogenesis of multiple …
[PDF][PDF] Association of chromosomal translocation and miRNA expression with the pathogenesis of multiple myeloma. Cell J. 2014; 16 (2): 99-110
Multiple myeloma (MM), is the second most common blood cancer after non-Hodgkin's
lymphoma. Genetic changes, structural and numerical chromosome anomalies, are involved …
lymphoma. Genetic changes, structural and numerical chromosome anomalies, are involved …
Effect of The Receptor Activator of Nuclear Factor кB and RANK Ligand on In Vitro Differentiation of Cord Blood CD133+ Hematopoietic Stem Cells to Osteoclasts
Receptor activator of nuclear factor-kappa B ligand (RANKL) appears to be an osteoclast-
activating factor, bearing an important role in the pathogenesis of multiple myeloma. Some …
activating factor, bearing an important role in the pathogenesis of multiple myeloma. Some …